Characterization of cell clones stably transfected with short form caspase-9: apoptotic resistance and Bcl-XL

Xiaolan Yi1, Jinzhao Wang, Dai-Wu Seol

  • 1Department of Cellular Biology and Anatomy, Medical College of Georgia, 1459 Laney Walker Blvd., Augusta, 30912, USA.

Insights

This study shows that inhibiting caspase-9 and up-regulating Bcl-XL makes cells resistant to apoptosis during ATP depletion. This dual resistance occurs at both cytosolic caspase activation and mitochondrial levels.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Biochemistry

Background:

  • Caspases are crucial for apoptosis initiation and progression.
  • ATP depletion triggers caspase activation (caspase-9, -8, -3) and apoptotic morphology.

Purpose of the Study:

  • To investigate the specific role of caspase-9 in ATP depletion-induced apoptosis.
  • To determine the mechanisms of cellular resistance to apoptosis.

Main Methods:

  • Transfection of renal epithelial cells with dominant-negative caspase-9S.
  • Assessing apoptosis, caspase activation, and cytochrome c release in wild-type vs. caspase-9S clones.
  • Analyzing Bcl-2 family protein expression (Bax, Bak, Bcl-2, Bcl-XL).

Main Results:

  • Caspase-9S clones exhibited significant resistance to ATP depletion-induced apoptosis.
  • Inhibition of caspase activation and reduced cytochrome c release were observed.
  • Resistance extended to the mitochondrial level, with inhibited Bax translocation.
  • Up-regulation of the anti-apoptotic protein Bcl-XL was noted in resistant clones.

Conclusions:

  • Cells resistant to apoptosis can be achieved by inhibiting caspase-9 and up-regulating Bcl-XL.
  • This resistance operates at both cytosolic (caspase inhibition) and mitochondrial (Bcl-XL mediated) levels.
  • The findings provide insights into apoptotic pathway regulation and potential therapeutic strategies.